Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGALS3 | P17931 | 2/20 | 0.52 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.52 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.51 |
| ▸ | AMY2A | P04746 | 4/20 | 0.48 |
| ▸ | AMY1A | P0DUB6 | 2/20 | 0.47 |
| ▸ | CD69 | Q07108 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
| ▸ | SELL | P14151 | 2/20 | 0.44 |
| ▸ | SELP | P16109 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 4/20 | 0.43 |
| ▸ | MGAM | O43451 | 2/20 | 0.43 |
| ▸ | SI | P14410 | 1/20 | 0.43 |
| ▸ | CNR1 | P21554 | 1/20 | 0.43 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.43 |
| ▸ | PDE4A | P27815 | 1/20 | 0.43 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.43 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.43 |
| ▸ | GLA | P06280 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29381866 | 1.00 | LGALS3 (0.52) | LGALS3LGALS8LGALS4MAPK1AMY2A | |
| SCHEMBL29434721 | 1.00 | LGALS3 (0.52) | LGALS3LGALS8LGALS4MAPK1AMY2A | |
| SCHEMBL29632893 | 1.00 | LGALS3 (0.52) | LGALS3LGALS8LGALS4MAPK1AMY2A | |
| SCHEMBL29400853 | 1.00 | LGALS3 (0.52) | LGALS3LGALS8LGALS4MAPK1AMY2A | |
| SCHEMBL29130820 | 1.00 | LGALS3 (0.52) | LGALS3LGALS8LGALS4MAPK1AMY2A | |
| SCHEMBL10086038 | 1.00 | LGALS3 (0.52) | LGALS3LGALS8LGALS4MAPK1AMY2A | |
| SCHEMBL30478261 | 0.97 | LGALS3 (0.52) | LGALS3LGALS8LGALS4MAPK1AMY2A | |
| SCHEMBL11505202 | 0.97 | LGALS3 (0.55) | LGALS3LGALS8LGALS4MAPK1AMY2A | |
| SCHEMBL20516505 | 0.97 | LGALS3 (0.55) | LGALS3LGALS8LGALS4MAPK1AMY2A | |
| SCHEMBL14268511 | 0.97 | LGALS3 (0.55) | LGALS3LGALS8LGALS4MAPK1AMY2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12576134-B2 | Antiviral lectin and uses thereof | ACADEMIA SINICA (TW) | 2026-03-17 | — | — | US | disclosed |
| EP-3846841-B1 | ANTIVIRAL FLT3 RECEPTOR INTERACTING LECTIN (FRIL) FROM LABLAB PURPUREOUS FOR THE PREVENTION OR TREATMENT OF ENVELOPED VIRUS INFECTIONS | ACADEMIA SINICA (TW) | 2025-05-07 | — | — | EP | disclosed |
| US-12110532-B2 | In vitro glycosylation of proteins and enzymes | DESIGN- ZYME LLC (US) | 2024-10-08 | — | — | US | disclosed |
| CN-111032083-B | Humanized antibodies against GLOBO H and their use in cancer therapy | 财团法人生物技术开发中心 | 2024-01-12 | — | — | CN | disclosed |
| CN-117298265-A | Dendritic cell targeted allergen nano vaccine and application thereof | 上海市第一人民医院 | 2023-12-29 | — | — | CN | disclosed |
| US-20230203557-A1 | IN VITRO GLYCOSYLATION OF PROTEINS AND ENZYMES | Design-Zyme LLC (US) | 2023-06-29 | — | — | US | disclosed |
| US-11643676-B2 | In vitro glycosylation of proteins and enzymes | Design-Zyme LLC (US) | 2023-05-09 | — | — | US | disclosed |
| US-11497788-B2 | Supramolecular glycosaminoglycans | NORTHWESTERN UNIVERSITY (US) | 2022-11-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11497788-B2 | Supramolecular glycosaminoglycans | HPSE, CD44, GHITM | LGALS3 36/4885LGALS8 38/4885LGALS4 28/4885 |
| US-12576134-B2 | Antiviral lectin and uses thereof | NEU3, NEU2, FUCA2 | LGALS3 31/4885LGALS8 44/4885LGALS4 82/4885 |
| US-20230203557-A1 | IN VITRO GLYCOSYLATION OF PROTEINS AND ENZYMES | ALDH7A1, OGA, DAO | LGALS3 732/4885LGALS8 1305/4885LGALS4 867/4885 |
| US-12110532-B2 | In vitro glycosylation of proteins and enzymes | ALDH7A1, OGA, DAO | LGALS3 732/4885LGALS8 1305/4885LGALS4 867/4885 |
| US-11643676-B2 | In vitro glycosylation of proteins and enzymes | ALDH7A1, OGA, DAO | LGALS3 732/4885LGALS8 1305/4885LGALS4 867/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.